Gefitinib is a kinase inhibitor. The mechanism of action of gefitinib is as a protein kinase inhibitor. Gefitinib is a drug used in the treatment of certain types of cancer. Acting in a similar manner to erlotinib (marketed as tarceva), gefitinib selectively targets the mutant proteins in malignant cells. It is marketed by astrazeneca under the trade name iressa.